Ignite Creation Date:
2025-12-25 @ 5:06 AM
Ignite Modification Date:
2025-12-26 @ 4:09 AM
Study NCT ID:
NCT01106027
Status:
TERMINATED
Last Update Posted:
2018-01-31
First Post:
2010-03-29
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Dosing Regimen of Eculizumab Added to Conventional Treatment in Positive Crossmatch Deceased Donor Kidney Transplant
Sponsor:
Mayo Clinic
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-03
Start Date Type:
ACTUAL
Primary Completion Date:
2016-08-19
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-08-19
Completion Date Type:
ACTUAL
First Submit Date:
2010-03-29
First Submit QC Date:
None
Study First Post Date:
2010-04-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-10-12
Results First Submit QC Date:
None
Results First Post Date:
2017-11-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-01-08
Last Update Post Date:
2018-01-31
Last Update Post Date Type:
ACTUAL